Open AccessErrors in the treatment of highly differentiated thyroid cancer as a multidisciplinary problem
Author(s) -
Н. И. Волкова,
Maria Merenkova
Publication year - 2021
Publication title -
medicinskij vestnik ûga rossii
Language(s) - English
Resource type - Journals
eISSN - 2618-7876
pISSN - 2219-8075
DOI - 10.21886/2219-8075-2021-12-2-92-95
Subject(s) - medicine , levothyroxine , thyroid cancer , cervical lymph nodes , papillary thyroid cancer , endocrine system , thyroid , cancer , lymph , radiology , surgery , pathology , hormone , metastasis
Highly dierentiated thyroid cancer is a common endocrine neoplasm with a favorable prognosis. However, errors in the treatment of this pathology can signicantly worsen the patient’s quality of life. Patient V., 65 years old, underwent an operation for papillary thyroid cancer with an injury to the recurrent laryngeal nerve in 2015. Only 6 months later, RAI therapy was performed with an insucient dose of RI, and levothyroxine was prescribed at a thyrotoxic dose, which led to the development of AF. Throughout the entire period after surgical treatment, biochemical remission could not be achieved, and in 2019, a control ultrasound scan revealed lymphadenopathy of the anterior cervical lymph nodes and metastases in the lungs.